Search Results - "Sharabiani, M.T.A."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer by Allin, D.M., Shaikh, R., Carter, P., Thway, K., Sharabiani, M.T.A., Gonzales-de-Castro, D., O'Leary, B., Garcia-Murillas, I., Bhide, S., Hubank, M., Harrington, K., Kim, D., Newbold, K.

    Published in European journal of cancer (1990) (01-11-2018)
    “…Conventional biomarkers in thyroid cancer are not disease specific and fluctuate in advanced disease, making interpretation difficult. Circulating tumour DNA…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Differentiated Thyroid Cancer in Children: A UK Multicentre Review and Review of the Literature by Lee, K.A., Sharabiani, M.T.A., Tumino, D., Wadsley, J., Gill, V., Gerrard, G., Sindhu, R., Gaze, M.N., Moss, L., Newbold, K.

    “…To obtain an overview of the management and outcomes of children aged 18 years or younger diagnosed with differentiated thyroid carcinoma of follicular cell…”
    Get full text
    Journal Article